期刊文献+

噻托溴铵对慢性阻塞性肺疾病大鼠膈肌纤维的影响 被引量:2

Effects of Tiotropium Bromide on Diaphragm Fibers in A Rat Model of Chronic Obstructive Pulmonary Disease
原文传递
导出
摘要 目的探讨噻托溴铵对慢性阻塞性肺疾病(简称慢阻肺)大鼠膈肌功能的调节作用及其机制。方法 60只雄性Wistar大鼠随机分成对照组、慢阻肺组和噻托溴铵组。在慢阻肺组和噻托溴铵组采用烟熏及气管内注射脂多糖建立大鼠慢阻肺模型,噻托溴铵组大鼠在每次烟熏前30 min雾化吸入噻托溴铵(0.12 mmol/L,10 min)。第91 d将大鼠处死,观察各组大鼠肺组织的病理变化、膈肌纤维类型改变和膈肌细胞凋亡率的变化。结果肺组织病理学显示慢阻肺大鼠模型成功。噻托溴铵组大鼠肺气肿程度较慢阻肺组略轻。对照组大鼠膈肌Ⅱ型纤维比例为(64.64±1.86)%,Ⅰ型纤维比例为(36.24±2.25)%;慢阻肺组大鼠膈肌Ⅱ型纤维的比例显著降低,为(55.35±2.46)%,Ⅰ型纤维比例显著增加,为(48.82±2.34)%;噻托溴铵组介于对照组和慢阻肺组两组之间,Ⅱ型纤维比例为(59.38±2.56)%,Ⅰ型纤维比例为(40.83±1.22)%)。各组膈肌纤维比例差异有统计学意义(P<0.05)。3组大鼠膈肌细胞凋亡率分别为(1.73±0.87)%、(39.73±3.53)%和(25.48±3.35)%,组间差异有统计学意义(P<0.05)。结论噻托溴铵可抑制膈肌细胞过度凋亡,阻止慢阻肺大鼠膈肌纤维由Ⅱ型向Ⅰ型的转变,改善膈肌功能,缓解膈肌疲劳,延缓慢阻肺的进程。 Objective To explore the effects and mechanism of totropium bromide on diaphragm fibers remodeling in rats with chronic obstructive pulmonary disease (COPD). Methods 60 male Wistar rats were randomly divided into a control group, a COPD group and a tiotropium bromide group. The rat model of COPD was established by passive smoking and intratracheal instillation of lipopolysaccharide in the COPI) group and the tiotropium bromide group. The rats in the tiotropium bromide group were inhaled with tiotropium bromide (0.12 mmol/L, 10 min) 30 min before each smoking. Pathological changes of the lung tissue and airway were observed by HE staining. The diaphragm fibers classification was observed by dyeing. The diaphragmatic muscle cell apoptosis was observed by TUNEL. Results Histopathology proved that COPD rats model was successfully established. The emphysema in the tiotropium bromide group was milder than that in the COPD group. The type lI fibers and type I fibers of diaphragm accounted for (64. 64 ± 1.86) % and (36. 24 ± 2. 25 ) % in the control group, (55. 35 ± 2. d6) % and (48.82± 2. 34) % in the COPD group, (59. 38 ± 2. 56) % and (40. 83 ±1.22 ) % in the tiotropium bromide group, respectively. There were significant differences between three groups in category of diaphragm fibers ( P 〈 0. 05 ). The apoptosis rate of diaphragmatic muscle cells in three groups was ( 1.73 ± 0. 87) %, ( 39.73 ±3.53 ) % and (25.48 ±3.35 ) %, respectively, with significant difference between three groups ( P 〈 0.05 ). Conclusion Tiotropium bromide can inhibit over apoptosis of diaphragmatic muscle ceils and prevent diaphragm transfome from type ~ to type I in COPD rats, can alleviate diaphragmatic muscle fatigue and the progression of COPD.
出处 《中国呼吸与危重监护杂志》 CAS 2014年第4期344-347,共4页 Chinese Journal of Respiratory and Critical Care Medicine
基金 南京市科技发展计划(编号:YKK10103)
关键词 慢性阻塞性肺疾病 噻托溴铵 膈肌纤维 Chronic obstructive pulmonary disease Tiotropium bromide Diaphragm fibers
  • 相关文献

参考文献9

  • 1Ottenheijm CA, Heunks LM, Dekhuijzen RP. Diaphragm adaptations in patients with COPD. Respir Res,2008,24:9-12.
  • 2宋一平,崔德健,茅培英,王德文.慢性阻塞性肺疾病大鼠模型的建立及药物干预的影响[J].中华内科杂志,2000,39(8):556-557. 被引量:255
  • 3Clanton TL, Levine S. Respiratory muscle fiber remodeling in chronic hyperinflation: dysfunction or adaptation. J Appl Physiol, 2009,107 : 324-335.
  • 4Levine S, Nguyen T, Kaiser LR, et al. Human diaphragm remodeling associated with chronic obstructive pulmonary disease: clinical implications. Am J Respir Crit Care Med,2003 ,168 :706-713.
  • 5Cooper CB, Celli BR, Jardim JR, et al. Treadmill endurance during 2- year treatment with tiotropium in patients with COPD : a randomized trial. Chest ,2013,144:490-497.
  • 6Bedard ME, Brouillard C, Pepin V, et al. Tiotropium improves walking endurance in COPD. Eur Respir J ,2012,39:265-271.
  • 7Vacca G, Randerath WJ, Gillissen A. Inhibition of granulocyte migration by tiotropium bromide. Respir Res ,2011,27:12-24.
  • 8何牡丹,荣令,周新.噻托溴铵在COPD大鼠气道炎症中的作用[J].中国呼吸与危重监护杂志,2009,8(3):212-215. 被引量:18
  • 9Polla B, D'Antona G, Bottinelli R, et al. Respiratory muscle fibres: specialisation and plasticity. Thorax, 2004,59 : 808 -817.

二级参考文献18

  • 1张永,程德云,王慧,苏巧俐,陈小菊,关键.慢性阻塞性肺疾病大鼠肺内白细胞介素-8和肿瘤坏死因子-α与气道炎症的关系研究[J].中国呼吸与危重监护杂志,2003,2(6):355-359. 被引量:41
  • 2张弛,林如平,刘洪,陈云凤.鱼腥草注射液对慢性阻塞性肺疾病患者炎症细胞因子与肺功能的影响[J].中国中医药科技,2006,13(5):294-295. 被引量:18
  • 3Profita M, Giorgi RD, Sala A, et al. Muscarinic receptors,leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy,2005,60 : 1361-1369.
  • 4Jimenez E, Montiel M. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells. J Cell Physiol,2005 ,204 :678-686.
  • 5Sato E, Koyama S, Okubo Y, et al. Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. Am J Physiol, 1998,274 : L970-L979.
  • 6Tashkin DP,Celli B,Senn S,et al. A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease. N Engl J Med,2008,359: 1543-1554.
  • 7Saito Y, Azuma A, Morimoto T, et al. Tiotropium ameliorates symptoms in patients with chronic airway mucus hypersecretion which is resistant to Macrolide therapy. Intern Med,2008,47:585-591.
  • 8Profita M, Bonanno A, Siena L, et al. Acetylcholine mediates the release of IL-8 in human bronchial cells by a NFKB/ERK- dependent mechanism. Eur J Pharmaeol,2008 ,582 :145-153.
  • 9Buhling F, Lieder N, Kuhlmann UC, et al Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro. Respir Med,2007,101 : 2386-2394.
  • 10Gosens R,Bos IS, Zaagsma J, et al. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med,2005,171 : 1096-1102.

共引文献270

同被引文献21

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部